June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
A triple-negative breast cancer trial has its first success story
October 12, 2018 | Maxine Nunes
Linda Collins's outlook was bleak, thanks to her triple-negative breast cancer diagnosis, until City of Hope oncologist Yuan Yuan, M.D., Ph.D. helped develop a revolutionary new trial to help her.
New hormone and immunotherapy trial for breast cancer patients
October 8, 2018 | City of Hope
This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.
New Study: Deploying Genetic Screens Early May Offer Some Benefits
February 7, 2017 | Jyoti Madhusoodanan
Next-generation sequencing (NGS) tests can quickly pinpoint tumor mutations that can be targeted with specific drugs, offering a route to precision therapies for many cancer types. Coupled with new drugs that target tumor-specific genomic changes, NGS tests carry the potential to transform modern cancer care.
World Cancer Day: New treatments and cures start with collaborations
February 3, 2017 | Denise Heady
Defeating cancer cannot be done alone. It requires a team approach. Here are just a few examples of how City of Hope scientists and physicians are working together to create leading-edge approaches to end cancer.